As shown in Table 1, PIO treatment significantly lowered blood glucose, serum BUN, and creatinine in diabetic apoE (-/-) mice (P < 0.05 vs. no treatment group), but these effect were not observed among non-diabetes groups. The gene discussed is APOE; the disease is diabetes mellitus.